/content/dam/www/people-profile-photos/g/peter-gilbert/peter-gilbert-d.jpg
Gilbert
Peter Gilbert, PhD

Peter Gilbert, PhD

  • Professor, Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
  • Professor, Biostatistics Program, Public Health Sciences Division, Fred Hutch
  • Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
  • Principal Investigator, Statistical Data Management Center, HIV Vaccine Trials Network
  • Research Professor, Biostatistics, University of Washington
  • Graduate Faculty, Biostatistics, University of Washington
206.667.7299
206.667.4812

Background

Dr. Peter Gilbert is a biostatistician engaged in the design and analysis of clinical trials of candidate vaccines for HIV and other infectious diseases. His team specializes in data analyses of these trials to understand how vaccine efficacy depends on immune responses to vaccination and on genetic features of infectious pathogens — a field of biostatistics he pioneered named “sieve analysis.” His teaching and research interests include general biostatistical methods in areas including survival analysis, causal inference and evaluation of surrogate endpoints. He enjoys working with biostatistics graduate students on innovative statistical methods for vaccine clinical trials.

Education

University of Washington, 1996, PhD (Biostatistics)

University of Washington, 1994, MS (Biostatistics)

University of Washington, 1992, BS (Mathematics)

Research Interests

Vaccine clinical trials

Design and analysis of phase 2b vaccine clinical trials, for evaluating vaccine efficacy, immune correlates of protection, sieve analysis, and post-infection vaccine effects

Design and analysis of phase 2b/3 clinical trials of monoclonal antibodies for prevention of HIV infection

General biostatistical methods research, including survival analysis, causal inference, and evaluation of surrogate endpoints, especially involving immunology and virology data (e.g. pathogen sequences) integrated with clinical data

Current Projects

Leadership for the Statistical Data Management Center of the HIV Vaccine Trials Network

Leadership for Statistical Science for COVID-19 Vaccine Efficacy Trials

Statistical Methods in Vaccine Efficacy Trials for HIV and Other Genetically Diverse Pathogens

Statistical Methods for Monoclonal Antibody HIV Prevention Efficacy Trials

Find a Clinical Trial

Stories

All news
The benefits of HIV research? Let us count the ways HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts November 28, 2025
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science Award recognizes leadership in HIV vaccine trial development, analysis May 9, 2025
Crunching the numbers for next-gen COVID-19 vaccines BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design January 7, 2025